Pharmacogenomics Is A Field Of Medicine That Studies How Genes Can Affect Response To Drugs And It Can Be Used For Creating Targeted Therapies

 

Pharmacogenomics 

Pharmacogenomics is an emerging field in which genes, proteins and single nucleotide polymorphisms (SNPs) are studied to determine how people respond to specific drugs. This research will allow drug makers to create targeted therapies that target the disease and not just the symptoms.

The most common use of Pharmacogenomics is to identify the right drug for each individual patient, reducing the number of patients prescribed different drugs that may not work well for them or cause unwanted side effects. This is called personalized medicine. It can save time and money, as there is no need to go through trial-and-error with multiple medications until the right one is found.

People respond differently to medicines, some get better and others have no effect or side effects. Doctors use this information to find the best way to treat each person. Its part of the new field called precision medicine.

Using Pharmacogenomics to help find new ways of treating diseases is a big part of the field of "precision medicine." These medicines can be made only for people with specific genetic traits or a disease that's caused by those traits.

Pharmacogenomics can help doctors choose the best drug for an individual patient and avoid giving them too many of them that aren't likely to work. This will save patients money and reduce the number of medications they need to take. It will also help doctors select the best drugs for patients with chronic illnesses. This will save them time and reduce the number of medications they need to give each day.

Pharmacogenomics is a rapidly growing field that can be applied to many different aspects of medical care, from finding the best drug for an individual to making sure the right dose is given. It also can help doctors figure out which drugs will not cause problems for someone with a certain gene and which ones may cause serious side effects.

Predicting how a drug will react to a patient's genetic makeup is a challenge, as people often respond differently to different medicines. Some people may not have any symptoms at all when they are given a drug while others will have severe reactions that could require hospitalization or death.

Another major challenge is to predict when a company will need to develop a companion diagnostic assay to complement the drug. The goal of a companion diagnostic assay is to help doctors prescribe the correct dose of a drug to each individual patient. If this is not done, then many patients will experience side effects and won't get the full benefits of the drug.

The expanded Invitae Pharmacogenomics (PGx) Panel was launched by Invitae in May 2022. The panel includes specialized Invitae Pharmacogenomics Mental Health Panel.

Comments

Popular posts from this blog

With the use of High-Frequency alternating current, Radiofrequency Ablation Device convert Electromagnetic Energy into Heat Energy

The Isocyanates Market to Witness Robust Growth in North America and Asia Pacific

Air Purifier works as a Sanitizer in the air which helps in reducing pollutants, allergens, and toxins